Kim McClure

Vice President, Chemistry at Pinteon Therapeutics - , ,

Kim McClure's Colleagues at Pinteon Therapeutics
Kim McClure's Contact Details
HQ
Location
United States
Company
Pinteon Therapeutics
Kim McClure's Company Details
Pinteon Therapeutics logo, Pinteon Therapeutics contact details

Pinteon Therapeutics

, , • 9 Employees
Research

Pinteon Therapeutics is advancing clinical studies of a novel antibody that aims to interrupt the spread of toxic tau and protect and preserve brain function in patients with neurodegenerative disease. Pinteon's lead asset, PNT001, is the only antibody in development that targets cis-pT231 tau, a neurotoxic epitope which has been identified in multiple preclinical studies as a potent driver of neurodegenerative disease. Pinteon is led by an experienced management team with strong track records in CNS drug discovery and development and is funded by Morningside Ventures. For more information, visit pinteon.com.

Details about Pinteon Therapeutics
Frequently Asked Questions about Kim McClure
Kim McClure currently works for Pinteon Therapeutics.
Kim McClure's role at Pinteon Therapeutics is Vice President, Chemistry.
Kim McClure's email address is ***@pinteon.com. To view Kim McClure's full email address, please signup to ConnectPlex.
Kim McClure works in the Biotechnology industry.
Kim McClure's colleagues at Pinteon Therapeutics are and others.
Kim McClure's phone number is
See more information about Kim McClure